New Precision Medicine Approved for Specific Patients with Lung Cancer
Last week, the U.S. Food and Drug Administration (FDA) provided some good news for the lung cancer community during...
Last week, the U.S. Food and Drug Administration (FDA) provided some good news for the lung cancer community during...
Late last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the...
On the heels of the U.S. Food and Drug Administration’s approval of a combination of immune checkpoint inhibitors for...
Guest Post by Kelvin Lee, MD Roswell Park Cancer Institute
Guest Post by Dario C. Altieri, MD The Wistar Institute
The field of cancer immunotherapy broke new ground last week when the U.S. Food and Drug Administration (FDA) announced...
A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have...
Check out the 10 blog posts from 2014 that attracted the most attention. They cover a lot of ground,...
Lung cancer awareness month started hot on the heels of two exciting pieces of news that highlight the promise...
Guest Post By Fadlo R. Khuri, MD Winship Cancer Institute of Emory University